Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie's disease: a 10-year retrospective analysis

被引:6
|
作者
Spirito, Lorenzo [1 ]
Manfredi, Celeste [1 ]
La Rocca, Roberto [2 ]
Napolitano, Luigi [2 ]
Preto, Mirko [3 ]
Di Girolamo, Antonio [4 ]
Arcaniolo, Davide [1 ]
De Sio, Marco [1 ]
Creta, Massimiliano [2 ]
Longo, Nicola [2 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Unit Urol, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Unit Urol, I-80131 Naples, Italy
[3] Univ Turin, Molinette Hosp, AOU Citta Salute & Sci, Urol Clin, I-10126 Turin, Italy
[4] AORN Moscati, Urol Unit, I-83100 Avellino, Italy
关键词
ERECTILE DYSFUNCTION;
D O I
10.1038/s41443-023-00673-w
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The aim of this paper was to describe the long-term outcomes of extracorporeal shock wave therapy (ESWT) in patients with acute Peyronie'disease (PD). An observational retrospective study was conducted in men with acute PD who underwent ESWT between 2009-2013 at a single institution. ESWT protocol consisted of 1 session (3000 shock waves, 0.10-0.25 mJ/mm boolean AND 2, 4-6 Hz) per week for 4 weeks. Penile pain was chosen as the primary outcome. Penile curvature angle, erectile function, and satisfaction with ESWT were selected as secondary long-term outcomes. A total of 194 patients were included. The mean follow-up duration after ESWT was 125.6 months. Mean penile curvature worsened significantly at 3 months (18.3 vs. 21.5 degrees; p = 0.023) and 12 months (21.5 vs. 28.6 degrees; p = 0.001) and stabilized over the long-term (28.6 vs. 28.8 degrees; p = 0.335). Mean penile pain improved significantly at 3 months (6.5 vs. 3.1 points; p < 0.001) and 12 months (3.1 vs. 1.0 points; p = 0.001), remaining stable over time (1.0 vs. 1.0 points; p = 0.074). The mean five-item version of the International Index of Erectile Function (IIEF-5) increased significantly at 3 months (14.5 vs. 17.9 points; p = 0.001), remaining stable at 12 months (17.9 vs. 18.5 points; p = 0.082), and deteriorating in the long-term (18.5 vs. 15.8 points; p = 0.003). A high satisfaction rate with ESWT was recorded at 3 months (92.3%), remaining similar at 12 months (91.2%) and over the long-term (90.2%). No new acute phase and low rate of PD surgery (4.1%) were recorded in the long-term analysis. In patients with acute PD, ESWT seems to be associated with early and persistent relief of penile pain, transient improvement in erectile function, no significant effect on penile curvature, and a high rate of patient satisfaction constant over time.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 50 条
  • [11] Extracorporeal shock wave therapy (ESWT) in the treatment of Peyronie's disease
    Oeynhausen, D
    Oelbracht, K
    Zumbé, J
    AKTUELLE UROLOGIE, 2001, 32 : 58 - 60
  • [12] Extracorporeal shock wave therapy for Peyronie's disease: The patients' perspective
    Abdelbaky, A.
    Lawn, A.
    Nigam, R.
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 : 455 - 455
  • [13] A 10-year retrospective audit of long-term apomorphine use in Parkinson's disease
    Tyne, HL
    Parsons, J
    Sinnott, A
    Fox, S
    Steiger, MJ
    Fletcher, NA
    MOVEMENT DISORDERS, 2002, 17 : S75 - S76
  • [14] SUBJECTIVE OUTCOME MEASURES OF EXTRACORPOREAL SHOCK WAVE THERAPY FOR PEYRONIE'S DISEASE
    Rizvi, F.
    Alkhayal, S.
    John, G.
    Fletcher, M.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 124 - 124
  • [15] Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience
    Husain, J
    Lynn, NNK
    Jones, DK
    Collins, GN
    O'Reilly, PH
    BJU INTERNATIONAL, 2000, 86 (04) : 466 - 468
  • [16] A Critical assessment of extracorporeal shock-wave therapy for Peyronie’s disease
    Alberto Briganti
    Andrea Salonia
    Giuseppe Zanni
    Federico Dehò
    Nazareno Suardi
    Bruno Mazzoccoli
    Vincenzo Scattoni
    Francesco Montorsi
    Current Sexual Health Reports, 2004, 1 (1) : 19 - 23
  • [17] Extracorporeal shock wave therapy for Peyronie's disease: Exploratory meta-analysis of clinical trials
    Hauck, EW
    Mueller, UO
    Bschleipfer, T
    Schmelz, HU
    Diemer, T
    Weidner, W
    JOURNAL OF UROLOGY, 2004, 171 (02): : 740 - 745
  • [18] Shock wave therapy in Peyronie's disease
    Colombo, F
    Baroni, P
    Serrago, M
    Mantovani, F
    Patelli, E
    Pisani, E
    XI NATIONAL CONGRESS, 1997, : 277 - 281
  • [19] Extracorporeal shock wave therapy as first line treatment in patients with Peyronie's disease
    Palmieri, A.
    Imbimbo, C.
    Longo, N.
    Creta, M.
    Buonopane, R.
    Dalena, G.
    Vivaldi, O.
    Riccio, R.
    Mirone, V.
    UROLOGIA JOURNAL, 2009, 76 : S74 - S79
  • [20] Role of extracorporeal shock wave therapy in management of Peyronie's disease: A preliminary report
    Shimpi, Rajendra Kashinath
    Jain, Ravi Jineshkumar
    UROLOGY ANNALS, 2016, 8 (04) : 409 - 417